Trial Profile
A Phase 2 Study of the Safety and Efficacy of Oral Delafloxacin (DLX) in Community Acquired Pneumonia (CAP)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Nov 2012
Price :
$35
*
At a glance
- Drugs Delafloxacin (Primary)
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Adverse reactions; Therapeutic Use
- 26 Nov 2012 New trial record